Prevision Medicine raises $5.4M
Prevision Medicine announced a Seed round of $5.4M on 24 September 2026. The company operates in HealthTech and is based in Switzerland. It was founded by Philip Zimmermann, CEO & Co-Founder. Announced yesterday.
Founder
Philip Zimmermann
CEO & Co-Founder, Prevision Medicine
Outreach angles
- -Philip Zimmermann, who holds a Doctor of Engineering degree, founded Prevision Medicine after prior roles connected to Nebion and the Immunai Group.
- -Zimmermann's background includes work tied to ETH Zurich precision medicine research before commercializing the platform.
- -The seed round will fund regulatory clearances and operational expansion of the company's functional oncology testing platform across Europe.
Signals
SeedHealthcareDeep TechRegulated IndustryNew Market
Round details
Company: Prevision Medicine
Domain: previsionmedicine.com
Amount: $5.4M
Stage: Seed
Industry: HealthTech
Country: Switzerland
Announced: 24 September 2026
Other HealthTech raises
Recently funded in Switzerland